(Q61938016)
Statements
SAFE (English)
0 references
The Clinical Safety and Effectiveness of Repaglinide in Treatment-naive Type 2 Diabetes Subjects in China. A 16-week Multicentre, Prospective, Open Label, Non-interventional Study. (English)
0 references
March 2010
0 references
February 2011
0 references
2,033
0 references
18 year
0 references